Analyst Ratings for Adverum Biotechnologies (ADVM)
ADVM Rating Summary
ADVM Price Target Summary
- Highest: $5.50 (Mizuho)
- Lowest: $4.00 (RBC Capital)
- Average: $4.88
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$4.88 (+11.8%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$4.88 (+11.8%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/17/2025 | H.C. Wainwright | Matt Caufield | Downgrade | Neutral (Buy) |
5.00 (N/A) |
4.29 (4.36) |
1.63% | Details |
| 10/27/2025 | Chardan | Daniil Gataulin | Downgrade | Neutral (Buy) |
5.00 (33.00) |
4.18 (4.36) |
4.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
